Table 1. Hematochemical, clinical and biochemical data in LE, ME, HE groups before (pre) and after (post) 3-month monitored exercise.
Variable | LE (462±51 MOVEs) | ME (674±14 MOVEs) | HE (860±51 MOVEs) | |||
---|---|---|---|---|---|---|
Pre | Post | Pre | Post | Pre | Post | |
HbA1c, % | 7.5±0.7 | 7.3±0.6 | 7.4±0.3 | 7.0±0.2a | 7.9±0.4 | 7.6±0.3 |
Visceral adipose/total adipose tissue | 0.64±0.03 | 0.63±0.03 | 0.62±0.02 | 0.60±0.02 | 0.61±0.03 | 0.58±0.03a |
Paraoxonase activity, U/mL | 58.3±14.0 | 63.0±13.1 | 39.2±8.7 | 42.4±9.0a | 47.8±12.9 | 51.0±13.2b |
Arylesterase activity, U/mL | 25.0±2.0 | 25.6±3.0 | 18.7±2.5 | 19.9±2.3 | 18.9±2.3 | 20.4±2.4a |
Visceral adipose tissue, % variation | - | 0.7±2.1 | - | –0.1±2.3 | - | –8.4±4.1 |
Augmentation index, % variation | - | 118±69 | - | –14±24 | - | –142±103 |
Tail intensity, % variation median | - | 11.0±6.2 | - | –2.5±7.2 | - | –15.3±8.1c |
Tail moment, % variation median | - | 16.5±8.6 | - | –4.8±6.6 | - | 6.7±11.6 |
Values are presented as mean±standard error of mean.
LE, low exercise; ME, medium exercise; HE, high exercise; HbA1c, glycosylated hemoglobin.
aP<0.05, bP<0.01 and highly significant and significant compared to study entry, respectively, cP<0.05 significant compared to LE.